Experimental treatment tested for deadly childhood brain cancer
Disease control
Terminated
This study is testing whether Antineoplaston therapy can help control DIPG, a rare and aggressive brainstem tumor that currently has very limited treatment options. The trial is designed for children and adults with DIPG, including those who have tried standard treatments and tho…
Phase: PHASE2 • Sponsor: Burzynski Research Institute • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC